Brief: Realheart Postpones Scheduled Start Of First Clinical Study To 2025
13/11/2023 14:38
Nov 13 (Reuters) - Scandinavian Real Heart AB
HEART.ST :
* REALHEART PROVIDES AN UPDATE ON THE DEVELOPMENT AND
COMMERCIALIZATION OF ITS ARTIFICIAL HEART
* SCHEDULED START OF FIRST CLINICAL STUDY HAS BEEN POSTPONED
FROM
2024 TO 2025
Source text for Eikon: ID:nWkr8QPqYR
Further company coverage: HEART.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))